ONCOMETHYLOME BIZ

[BIZ/LIFE-SCI: Liège, September 21]
The Liège-based biotech company OncoMethylome Sciences will achieve good test results in H2 2007 and try to use its development pipeline to reach commercial agreements, according to the MD Herman Sploders. The company also wants to get its products to market more quickly. It has already reported on the positive results for its urine tests for cancer of the bowel, and the results for the stool tests for colorectal cancer [reported on elsewhere in this issue. ED]. OncoMethylome develops tests that can detect cancer in its early stages. It also makes tests to predict the response of patients to treatment in order to estimate the likelihood of the return of cancer following treatment.
http://www.express.be/